Disease progression in chronic hepatitis C: Modifiable and nonmodifiable factors

被引:163
|
作者
Missiha, Sharif B. [1 ]
Ostrowski, Mario [1 ]
Heathcote, E. Jenny [1 ]
机构
[1] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
关键词
D O I
10.1053/j.gastro.2008.02.069
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The hepatic complications of chronic hepatitis C (CHC) usually occur only after progression to cirrhosis has taken place. Progression to cirrhosis, however, is extremely variable and depends on a broad set of host and viral factors that modify the rate at which fibrosis develops in a given individual. Despite their inherent limitations, studies of the natural history of CHC have identified several nonmodifiable factors associated with disease progression. These include age at acquisition of infection, sex, and race. More recent reports suggest important roles for host genetic polymorphisms and viral factors. Of greater immediate relevance to patients and their clinicians are the potentially modifiable factors, which include excessive alcohol consumption; smoking (tobacco and marijuana); insulin resistance; and coinfection with hepatitis B virus, human immunodeficiency virus type 1, or schistosomiasis. Unfortunately, to date, there are no reliable predictive models that can accurately estimate the risk of CHC disease progression.
引用
收藏
页码:1699 / 1714
页数:16
相关论文
共 50 条
  • [41] Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C
    Poynard, T
    Ratziu, V
    Charlotte, F
    Goodman, Z
    McHutchison, J
    Albrecht, J
    JOURNAL OF HEPATOLOGY, 2001, 34 (05) : 730 - 739
  • [42] Factors that predict progression to cirrhosis in chronic hepatitis C (case control study).
    Jamal, MM
    Quinn, PG
    Arora, S
    Harris, T
    Qualls, CR
    Johnston, DE
    HEPATOLOGY, 1997, 26 (04) : 63 - 63
  • [43] Environmental factors as disease accelerators during chronic hepatitis C
    Mallat, Ariane
    Hezode, Christophe
    Lotersztajn, Sophie
    JOURNAL OF HEPATOLOGY, 2008, 48 (04) : 657 - 665
  • [44] Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels
    Dong Hyun Sinn
    Geum-Youn Gwak
    Jae-uk Shin
    Moon Seok Choi
    Joon Hyeok Lee
    Kwang Cheol Koh
    Seung Woon Paik
    Byung Chul Yoo
    World Journal of Gastroenterology, 2013, (14) : 2256 - 2261
  • [45] Fibrosis and disease progression in hepatitis C
    Marcellin, P
    Asselah, T
    Boyer, N
    HEPATOLOGY, 2002, 36 (05) : S47 - S56
  • [46] Chronic hepatitis C virus infection: Predictive value of genotype on disease progression
    Fenoglio, LM
    Monasterolo, G
    Fruttero, M
    Peano, GM
    Carnevale, F
    Wulhfard, K
    Sabidussi, A
    Biarese, V
    GASTROENTEROLOGY, 1997, 112 (04) : A1263 - A1263
  • [47] Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Shin, Jae-uk
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Yoo, Byung Chul
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (14) : 2256 - 2261
  • [48] DETERMINANTS OF LIVER DISEASE PROGRESSION IN CHILDREN WITH CHRONIC HEPATITIS C VIRUS INFECTION
    Pokorska-Spiewak, Maria
    Kowalik-Mikolajewska, Barbara
    Aniszewska, Malgorzata
    Pluta, Magdalena
    Walewska-Zielecka, Bozena
    Marczynska, Magdalena
    POLISH JOURNAL OF PATHOLOGY, 2015, 66 (04) : 368 - 375
  • [49] CIRCULATING MICRORNAS AS BIOMARKERS FOR DISEASE PROGRESSION IN CHRONIC HEPATITIS C VIRUS INFECTION
    Bulteel, N.
    McGuinness, D.
    Shiels, P. G.
    McLauchlan, J.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S733 - S734
  • [50] Hepatitis C and progression of HIV disease
    Sulkowski, MS
    Moore, RD
    Mehta, SH
    Chaisson, RE
    Thomas, DL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (02): : 199 - 206